About
Bispecific Antibody
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodyNJ, NY, PA
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
64
By Phase
PHASE1: 2
By Status
RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06933043Collaborator
A Study on the Safety, Tolerability, Bioavailability and Mechanism of Action of Intravenous NAV-240 in Adults.
PHASE1Recruiting
24 participants
Started: May 20, 2025 · Completed: Nov 8, 2025
NCT06181786Lead Sponsor
Study of NAV-240 in Healthy Volunteers
PHASE1Completed
40 participants
Started: Nov 22, 2023 · Completed: Sep 4, 2024
Funding History (1)
D
Sep 5, 2024
Locations (1)
Headquarters
Scotch Plains, NJ, United States
Map
Loading map...